• Andrew Ramonas
    Lobbying Reporter
  • Beth Frerking
    Editor in Chief
  • David Brown
    Vice President/Editor, ALM
  • Diego Radzinschi
    Photo Editor
  • Jenna Greene
    Senior Reporter
  • Marcia Coyle
    Chief Washington Correspondent
  • Mike Scarcella
    Washington Bureau Chief
  • Todd Ruger
    Capitol Hill Reporter
  • Tony Mauro
    Supreme Court Correspondent
  • Zoe Tillman
    D.C. Courts Reporter

« Former White House Lawyer Lobbying for Microsoft on Antitrust Issues | Main | Dewey & LeBoeuf Loses Latest Partner to Schiff Hardin in D.C. »

May 07, 2012



The pharmaceutical business is a tough business because the drug companies always end up getting sued. There are so many regulations they have to pay attention to that, sometimes there is no way to be able to pass all the barriers and not get sued. However when they do violate the law, and people end up suing, the companies most of the time end up settling because the trials end up too costly. Pharmaceutical companies are targets for litigation and rightly so because of their use in society. If people and for that matter states cannot file against them, then the well-funded companies have indeed won in society.

The comments to this entry are closed.

Blog powered by Typepad